Schering in talks over Mitsui division purchase:
This article was originally published in Clinica
Executive Summary
Schering has confirmed it is in negotiations with Mitsui over the possible sale of the Japanese company's pharmaceutical division, which includes some X-ray contrast media. The German company would give no further details, but local Japanese press reports indicate that a contract could be signed as early as this month. The division would be integrated into Schering's Japanese unit, Nihon Schering KK, the press report says. Schering recently announced plans to buy US company Diatide and a major stake in ORIS/CIS Bio International of France.